Radient Technologies

About:

Radient Technologies engages in the extraction, purification, and isolation of naturally-derived compounds and ingredients.

Website: http://radientinc.com

Twitter/X: radientinc

Top Investors: VA Angels, Moskowitz Capital

Description:

Radient Technologies engages in the extraction, purification, and isolation of naturally derived compounds and ingredients. The company offers pharmaceutical intermediates from biomass for biotech and oncology companies, nutraceutical compounds from biomass for nutraceutical companies, and oil from spent biomass. It also provides clients to utilize its various solutions to produce compounds and ingredients under license. The company offers its products based on its MAP technology that involves the selective and localized heating of the moisture present in various natural materials using microwaves. It offers its products for use in the manufacture of pharmaceutical and bio-technology drugs, as well as for nutraceutical, food, and cosmetic products. The company was founded in 2001 and is headquartered in Edmonton, Canada. Radient Technologies is a former subsidiary of Vizon Scitec.

Total Funding Amount:

$10.2M

Estimated Revenue Range:

$1M to $10M

Headquarters Location:

Edmonton, Alberta, Canada

Founded Date:

2001-01-01

Contact Email:

enquiries(AT)radientinc.com

Founders:

Harry Kaura

Number of Employees:

51-100

Last Funding Date:

2023-04-20

IPO Status:

Public

Industries:

© 2025 bioDAO.ai